PARP inhibitors: their applications and efficacy against prostate cancer

2022 ASCO Genitourinary Cancers Symposium Research Updates Webinar with Dr. Alexandra SokolovaПодробнее

Role of PARP Inhibitors in Prostate CancerПодробнее

Dr. Higano Discusses PARP Inhibitors in Prostate CancerПодробнее

The Role of PARP Inhibitors in Advanced Prostate CancerПодробнее

Dr. Dorff Discusses the Use of PARP Inhibitors in Prostate CancerПодробнее

PARP Inhibitors in Advanced Prostate Cancer CareПодробнее

PARP Inhibitors for Prostate CancerПодробнее

Choosing the correct PARP inhibitor for prostate cancerПодробнее

Targeting Advanced Prostate Cancer with PARP inhibitors: Who, When and How?Подробнее

PARP inhibitors and their evolving role for the treatment of prostate cancerПодробнее

Dr. Morgan on the Role of PARP Inhibitors in Prostate CancerПодробнее

The Role of Targeting DNA Repair with PARPПодробнее

LuPARP: 177Lu-PSMA-617 and PARP inhibitor combination for prostate cancerПодробнее

PARP Inhibitors for Prostate Cancer with Moshe Ornstein, MDПодробнее

Which mutations benefit most from PARP inhibitors in prostate cancer?Подробнее

The emerging role of PARP inhibitors in prostate cancerПодробнее

Dr. Hussain Discusses PARP Inhibitors in Prostate CancerПодробнее

Current perspectives from clinical trials using PARP inhibitors for prostate cancerПодробнее

Comment: PARP inhibitors for advanced prostate cancerПодробнее

PARP Inhibitors in Castrate-Resistant Prostate CancerПодробнее